Copper(II) N,N,O-Chelating Complexes as Potential Anticancer Agents

Area of Science:

• Coordination Chemistry
• Materials Science
• Biomedical Applications

Background:

• Metal complexes are explored for cancer therapy.
• Reactive oxygen species (ROS) generation is a key mechanism for cancer cell death.
• Copper complexes offer redox activity within biological windows.

Purpose of the Study:

• Synthesize and characterize novel dinuclear Cu(II) complexes.
• Investigate the structural behavior in solid-state and solution.
• Evaluate the potential of these complexes as ROS generators and their selective cytotoxicity against cancer cells.

Main Methods:

• Synthesis and characterization of three dinuclear Cu(II) complexes.
• X-ray crystallography and computational studies for structural analysis.
• Mass spectrometry and electron paramagnetic resonance (EPR) for solution behavior.
• In vitro cytotoxicity assays on HeLa, MCF7, and normal fibroblast cell lines.

Main Results:

• Novel dinuclear Cu(II) complexes with varying aromatic substituents were synthesized.
• Complexes exhibit dimeric structure in solid-state and coexist with monomeric form in solution.
• High potential as ROS generators with Cu(II)/Cu(I) redox cycling capability.
• Promising selective cytotoxicity against HeLa and MCF7 cancer cell lines (IC50 ~25 μM in HeLa).

Conclusions:

• The N,N,O-chelating salphen-like ligand scaffold is effective for designing Cu(II) complexes.
• These complexes demonstrate potential for selective cancer cell death via ROS generation.
• The developed Cu(II) complexes represent a promising platform for future anticancer drug development.